Part-Time

Variant Interpretation

Adjunct Pool

Posted on 5/9/2026

KGI

KGI

501-1,000 employees

Graduate programs in applied life sciences

Compensation Overview

$2.5k - $15k/mo

Pomona, CA, USA

In Person

Category
Education
Requirements
  • Must hold a master’s degree, Ph.D. preferred, in human genetics or related field
Responsibilities
  • Provides high-quality student instruction
  • Evaluates student performance (e.g., written assignments, examinations, in-class activities)
  • Provides remedial instruction as needed
Desired Qualifications
  • Experience with medical genetics and germline variant curation
  • An ability to work effectively in a team environment
  • Prior experience in teaching for active learning preferred
  • Experience with the Canvas learning management system is a plus

KGI provides graduate programs in applied life sciences for the biopharma, medical device, diagnostics, and healthcare industries. It offers the Master of Business and Science (MBS), Master of Science degrees, a PhD in Applied Life Sciences, and a PharmD across three schools, blending bioscience with management, engineering, and finance, with hands-on learning through Team Master’s Projects sponsored by industry partners. It differentiates itself by focusing on translational, industry-connected education linked to The Claremont Colleges and by supporting spin-outs like Ionian Technologies. Its goal is to train leaders who bridge science, engineering, and business to advance the biotech and healthcare sectors and accelerate translational medicine.

Company Size

501-1,000

Company Stage

Grant

Total Funding

$1.8M

Headquarters

Claremont, California

Founded

1997

Simplify Jobs

Simplify's Take

What believers are saying

  • Terasaki Institute partnership expands PhD training, shared labs, and joint grant funding through 2029.
  • Accelerated one-year MSMDE program launched 2019 captures rapid MedTech workforce demand.
  • New leadership under President Abousalem and Dean Garza positions pharmacy and research expansion.

What critics are saying

  • Enrollment stagnation at 617 students amid competition from USC's larger PharmD programs.
  • Tuition-dependent revenue model vulnerable to biotech hiring slowdown and industry layoffs.
  • Terasaki partnership expires 2029; non-renewal eliminates shared infrastructure and grant funding.

What makes KGI unique

  • Only U.S. graduate institution exclusively dedicated to applied life sciences education and research.
  • Ranked #3 master's program nationally, behind only MIT and Stanford, as of 2025.
  • Team Master's Project model delivers 90% employment within six months post-graduation.

Help us improve and share your feedback! Did you find this helpful?

Benefits

-

Growth & Insights and Company News

Headcount

6 month growth

5%

1 year growth

6%

2 year growth

6%
American Association for the Advancement of Science (AAAS)
Mar 9th, 2026
Terasaki Institute and Keck Graduate Institute launch partnership to advance biomedical innovation

Terasaki Institute and Keck Graduate Institute launch partnership to advance biomedical innovation. New collaboration expands interdisciplinary research, shared facilities, and graduate training opportunities in the life sciences Terasaki Institute for Biomedical Innovation Los Angeles, CA - March 9, 2026 - The Terasaki Institute for Biomedical Innovation (TIBI) and Keck Graduate Institute (KGI) have announced a new collaborative research partnership designed to accelerate biomedical innovation through joint research programs, faculty collaboration, and expanded student training opportunities. The agreement establishes a framework for long-term collaboration between the two Southern California institutions, enabling interdisciplinary research initiatives, reciprocal faculty affiliations, shared laboratory infrastructure, and expanded educational programs. The collaboration will support research across multiple areas of biomedical innovation, including biomaterials, cell engineering, drug delivery technologies, medical devices, and personalized medicine. "This partnership reflects our shared commitment to advancing scientific discovery through collaboration," said Stewart Han, President of the Terasaki Institute for Biomedical Innovation. "By combining the complementary expertise of our institutions, we can accelerate the development of technologies that improve patient care while providing meaningful research opportunities for students and scientists." The partnership will allow researchers from both institutions to pursue joint grant proposals, collaborative research projects, and co-authored publications. Scientists will also gain reciprocal access to specialized research infrastructure, including laboratory space, core instrumentation, libraries, and animal research facilities. The collaboration will also create new opportunities for PhD student training and mentorship. KGI doctoral students will have the opportunity to conduct research in Terasaki Institute laboratories under the supervision of principal investigators, strengthening hands-on research training and interdisciplinary collaboration. "Collaborative partnerships are essential to advancing innovation in the life sciences," said Dr. Loren Martin, Associate Vice Provost of Research, Innovation, and Partnerships at Keck Graduate Institute. "Working with the Terasaki Institute will expand opportunities for our faculty and students to engage in impactful research while strengthening the connection between discovery and real-world application." The institutions will also collaborate on scientific symposia, speaker series, and summer research programs for undergraduate and high school students. The partnership will be guided by a joint Collaborative Research Steering Committee, which will coordinate research initiatives, identify funding opportunities, and evaluate progress of the collaboration. The agreement will initially run for three years, with the potential for renewal as new research programs develop. About the Terasaki Institute for Biomedical Innovation The Terasaki Institute for Biomedical Innovation is a non-profit research organization that invents and fosters practical solutions that restore or enhance the health of individuals. The Institute aims to enhance the quality of human life through translational research and the acceleration of biomedical innovation. TIBI's research focuses on the development of biomaterials, cellular and tissue engineering, medical devices, and microfluidic systems. About Keck Graduate Institute A proud member of The Claremont Colleges, Keck Graduate Institute (KGI) offers innovative master's and doctoral programs in critical high-growth areas to directly address industry needs in biotechnology and healthcare. KGI is dedicated to educating and empowering the ethical innovative leaders in biotechnology, healthcare, and life sciences who will heal and uplift communities locally and beyond. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

The Orange County Register
Aug 28th, 2025
Partnership offers Santiago Canyon College students a pathway to a PharmD degree

As the fall semester begins, Santiago Canyon College is launching a new partnership with Keck Graduate Institute to provide students with an accelerated pathway to a doctor of pharmacy degree.

The Manila Times
Oct 30th, 2024
Keck Graduate Institute Welcomes Oscar Garza as School of Pharmacy Dean

Keck Graduate Institute welcomes Oscar Garza as School of Pharmacy dean.

Global Energy Times
Sep 19th, 2024
Keck Graduate Institute Awarded $750,000 Grant from the Department of Energy to Study Low-Level Radiation Effects

Los Alamos National Laboratory was awarded the same amount and will work with KGI on the project.

Claremont Courier
Jul 5th, 2024
KGI welcomes new president

Abousalem joins KGI from San Jose State University, where he served as its inaugural vice president for research and innovation.